We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+42.78%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
+$275M
Cap. Flow
+$223M
Cap. Flow %
22.14%
Top 10 Hldgs %
24.16%
Holding
3,706
New
246
Increased
2,543
Reduced
445
Closed
132

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$11.6M
2
NVDA icon
NVIDIA
NVDA
+$8.23M
3
MSFT icon
Microsoft
MSFT
+$7.53M
4
AMZN icon
Amazon
AMZN
+$3.51M
5
META icon
Meta Platforms (Facebook)
META
+$3.34M

Top Sells

Rank Stock Value
1
IBHE
iShares iBonds 2025 Term High Yield and Income ETF
IBHE
+$1.21M
2
IBHD
iShares iBonds 2024 Term High Yield and Income ETF
IBHD
+$1.11M
3
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
+$1M
4
CVX icon
Chevron
CVX
+$216K
5
MRNA icon
Moderna
MRNA
+$178K

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Financials 11.78%
3 Healthcare 9.71%
4 Industrials 7.92%
5 Consumer Discretionary 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBBY
3151
Bed Bath & Beyond
BBBY
$442M
$151 ﹤0.01%
17
+7
+70% +$72
TSBK icon
3152
Timberland Bancorp
TSBK
$351M
$151 ﹤0.01%
+5
New +$146
OFLX icon
3153
Omega Flex
OFLX
$312M
$150 ﹤0.01%
3
-31
-91% -$1.53K
FDBC icon
3154
Fidelity D&D Bancorp
FDBC
$317M
$148 ﹤0.01%
+3
New +$148
HOUS
3155
DELISTED
Anywhere Real Estate
HOUS
$147 ﹤0.01%
29
-7,360
-100% -$34.1K
SYRE icon
3156
Spyre Therapeutics
SYRE
$9.25B
$147 ﹤0.01%
+5
New +$139
JBI icon
3157
Janus International
JBI
$757M
$142 ﹤0.01%
14
– –
INZY
3158
DELISTED
Inozyme Pharma
INZY
$141 ﹤0.01%
27
+3
+13% +$16
INO icon
3159
Inovio Pharmaceuticals
INO
$69M
$139 ﹤0.01%
+24
New +$198
GRPN icon
3160
Groupon
GRPN
$1.02B
$137 ﹤0.01%
+14
New +$188
ALDX icon
3161
Aldeyra Therapeutics
ALDX
$93.5M
$135 ﹤0.01%
+25
New +$119
ECF
3162
Ellsworth Growth & Income Fund
ECF
$172M
$135 ﹤0.01%
15
– –
KRRO icon
3163
Korro Bio
KRRO
$195M
$134 ﹤0.01%
+4
New +$168
SRI icon
3164
Stoneridge
SRI
$213M
$134 ﹤0.01%
12
-11
-48% -$157
GOLD
3165
Gold.com Inc
GOLD
$1.26B
$132 ﹤0.01%
3
+1
+50% +$38
PLPC icon
3166
Preformed Line Products
PLPC
$2.28B
$128 ﹤0.01%
1
-9
-90% -$1.09K
PGY icon
3167
Pagaya Technologies
PGY
$1.78B
$127 ﹤0.01%
+12
New +$158
GBIO
3168
DELISTED
Generation Bio
GBIO
$124 ﹤0.01%
5
-3
-38% -$79
RCI icon
3169
Rogers Communications
RCI
$18.6B
$121 ﹤0.01%
3
-37
-93% -$1.45K
SEAT icon
3170
Vivid Seats
SEAT
$85.4M
$107 ﹤0.01%
1
-4
-80% -$364
CURV icon
3171
Torrid Holdings
CURV
$260M
$106 ﹤0.01%
+27
New +$182
SABR icon
3172
Sabre
SABR
$835M
$99 ﹤0.01%
+27
New +$84
FCEL icon
3173
FuelCell Energy
FCEL
$1.63B
$84 ﹤0.01%
7
– –
BDRX
3174
Biodexa Pharmaceuticals
BDRX
$1.58M
– –
-3
Closed -$2.3K
MDWD icon
3175
MediWound
MDWD
$185M
$72 ﹤0.01%
+4
New +$73
125 126
127
128 129

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
HC
Henshaw Capital Woburn, Massachusetts $2.7B AUM 29.67% 1-Year Est. Return
CI
Capital International Los Angeles, California $2.7B AUM 31.08% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

GAMMA Investing's Q3 2024 Portfolio in Review

As of Q3 2024, GAMMA Investing held 3,706 positions worth $1.01B, up 37% from $734M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

GAMMA Investing deployed $223M of net new capital in Q3 2024, opening 246 new positions and adding to 2,543 existing holdings. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 28,428 shares worth $2.61M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Chevron, an estimated $216K trimmed.

  • GAMMA Investing's largest Q3 2024 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 28,428 shares worth $2.61M.
  • GAMMA Investing added most to Apple in Q3 2024, an estimated $11.6M increase.
  • GAMMA Investing's biggest Q3 2024 reduction was Chevron, cutting an estimated $216K.
  • GAMMA Investing fully exited iShares iBonds 2025 Term High Yield and Income ETF in Q3 2024, selling an estimated $1.21M.
  • GAMMA Investing's ten largest holdings make up 24% of its $1.01B portfolio in Q3 2024.
  • GAMMA Investing opened 246 new positions and closed 132 in Q3 2024.
  • GAMMA Investing's portfolio value rose 37% quarter-over-quarter to $1.01B.

Based on GAMMA Investing's 13F filing for Q3 2024, filed 7 Oct 2024.